BR9708614A - Derivado de ácido carboxílico e utilização de um composto e de uma combinação de um composto - Google Patents

Derivado de ácido carboxílico e utilização de um composto e de uma combinação de um composto

Info

Publication number
BR9708614A
BR9708614A BR9708614A BR9708614A BR9708614A BR 9708614 A BR9708614 A BR 9708614A BR 9708614 A BR9708614 A BR 9708614A BR 9708614 A BR9708614 A BR 9708614A BR 9708614 A BR9708614 A BR 9708614A
Authority
BR
Brazil
Prior art keywords
compound
combination
carboxylic acid
acid derivative
derivative
Prior art date
Application number
BR9708614A
Other languages
English (en)
Inventor
Wilhelm Amberg
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of BR9708614A publication Critical patent/BR9708614A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR9708614A 1996-04-12 1997-04-04 Derivado de ácido carboxílico e utilização de um composto e de uma combinação de um composto BR9708614A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19614542A DE19614542A1 (de) 1996-04-12 1996-04-12 Neue Carbonsäurederivate, ihre Herstellung und Verwendung
PCT/EP1997/001687 WO1997038982A1 (de) 1996-04-12 1997-04-04 Neue carbonsäurederivate, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
BR9708614A true BR9708614A (pt) 1999-08-03

Family

ID=7791123

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9708614A BR9708614A (pt) 1996-04-12 1997-04-04 Derivado de ácido carboxílico e utilização de um composto e de uma combinação de um composto

Country Status (23)

Country Link
US (1) US6103732A (pt)
EP (1) EP0892788A1 (pt)
JP (1) JP2000508325A (pt)
KR (1) KR20000005366A (pt)
CN (1) CN1216042A (pt)
AR (1) AR006593A1 (pt)
AU (1) AU711293B2 (pt)
BG (1) BG63202B1 (pt)
BR (1) BR9708614A (pt)
CA (1) CA2250764A1 (pt)
CO (1) CO4900038A1 (pt)
DE (1) DE19614542A1 (pt)
HR (1) HRP970200A2 (pt)
ID (1) ID19050A (pt)
IL (1) IL126026A0 (pt)
NO (1) NO311802B1 (pt)
NZ (1) NZ331704A (pt)
PL (1) PL329240A1 (pt)
SK (1) SK127698A3 (pt)
TR (1) TR199802042T2 (pt)
TW (1) TW419465B (pt)
WO (1) WO1997038982A1 (pt)
ZA (1) ZA973096B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL130251A0 (en) 1996-12-18 2000-06-01 Basf Ag Heterocyclic carboxylic acid derivatives the production and use thereof as endothelin receptor antagonists
US6030975A (en) * 1997-03-14 2000-02-29 Basf Aktiengesellschaft Carboxylic acid derivatives, their preparation and use in treating cancer
HUP0004935A3 (en) * 1997-09-04 2001-12-28 Basf Ag Novel carboxylic acid derivatives, their production and their use as mixed eta/etb endothelin-receptor antagonists
DE69838042T2 (de) * 1997-10-17 2008-03-06 Ark Therapeutics Ltd. Verwendung von Inhibitoren des Renin-Angiotensin Systems
US7566452B1 (en) 1999-05-04 2009-07-28 New York University Cancer treatment with endothelin receptor antagonists
DE60120104T2 (de) * 2001-03-20 2006-09-21 Schwarz Pharma Ag Neue Verwendung von Peptidverbindungen bei der Behandlung von nicht-neuropathischem Entzündungsschmerz
DE60100055T2 (de) * 2001-03-21 2003-07-24 Sanol Arznei Schwarz Gmbh Neue Verwendung einer Klasse von Peptidverbindungen zur Behandlung von Allodynie oder andere Arten von chronischen oder Phantomschmerzen
WO2005099740A1 (en) 2004-04-16 2005-10-27 Schwarz Pharma Ag Use of peptidic compounds for the prophylaxis and treatment of chronic headache
JP2008510758A (ja) * 2004-08-27 2008-04-10 シュヴァルツ・ファーマ・アーゲー 骨肉腫の痛み、化学療法誘発性及びヌクレオシド誘発性の痛みを治療するためのペプチド化合物の新規使用
EP1754476A1 (en) * 2005-08-18 2007-02-21 Schwarz Pharma Ag Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia
US20070043120A1 (en) * 2005-08-18 2007-02-22 Bettina Beyreuther Therapeutic combination for painful medical conditions
US20070048372A1 (en) * 2005-08-18 2007-03-01 Srz Properties, Inc. Method for treating non-inflammatory osteoarthritic pain
JP5443981B2 (ja) 2006-06-15 2014-03-19 ウーツェーベー ファルマ ゲーエムベーハー 相乗的抗痙攣効果を有する医薬組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2882195A (en) * 1994-06-27 1996-01-19 Ciba-Geigy Ag Pyrimidinyl- and triazinyl-oxy and thio-3-haloalkyl-propionic acid derivatives as herbicides

Also Published As

Publication number Publication date
US6103732A (en) 2000-08-15
ID19050A (id) 1998-06-04
BG102770A (en) 1999-11-30
HRP970200A2 (en) 1998-04-30
NO311802B1 (no) 2002-01-28
AU711293B2 (en) 1999-10-07
NO984713D0 (no) 1998-10-09
BG63202B1 (bg) 2001-06-29
ZA973096B (en) 1998-10-12
AU2636497A (en) 1997-11-07
CN1216042A (zh) 1999-05-05
KR20000005366A (ko) 2000-01-25
DE19614542A1 (de) 1997-10-16
NZ331704A (en) 2000-06-23
NO984713L (no) 1998-10-09
WO1997038982A1 (de) 1997-10-23
AR006593A1 (es) 1999-09-08
CO4900038A1 (es) 2000-03-27
IL126026A0 (en) 1999-05-09
TR199802042T2 (xx) 2000-09-21
JP2000508325A (ja) 2000-07-04
TW419465B (en) 2001-01-21
PL329240A1 (en) 1999-03-15
CA2250764A1 (en) 1997-10-23
SK127698A3 (en) 2000-03-13
EP0892788A1 (de) 1999-01-27

Similar Documents

Publication Publication Date Title
BR9510256A (pt) Derivados de ácido 3-aril-tetrônico
NO924978D0 (no) Chinolon- og naftyridon-karboksylsyrederivater
DE69703385D1 (de) Alkoxyessigsäure-derivate
NO990821D0 (no) Arylsulfonylamino-hydroksaminsyre-derivater
PT874558E (pt) Composicoes liquidas orais compreendendo um composto de calcio e um acidulante
EE03765B1 (et) Propioonhappe derivaadid ja nende kasutamine
KR970707080A (ko) 2-시아노아크릴산 에스테르(2-cyanoacrylic acid esters)
NO2011015I1 (no) Pallperidon palmitatester
FI950910A0 (fi) Rasvahappojohdannaiset
HUP0105027A3 (en) Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds and their use
DE59700915D1 (de) Stabilisierter Milchsäurementhylester
PT868183E (pt) Formulacoes injectaveis de quinolona
NO994595L (no) Salt av naftyridin-karboksylsyrederivat
BR9708614A (pt) Derivado de ácido carboxílico e utilização de um composto e de uma combinação de um composto
BR9708609A (pt) Derivado de ácido carboxilico e usos de compostos e de uma combinação de composto
FI954007A (fi) Substituoitujen 4-fenyyli-6-amino-nikotiinihappojohdannaisten käyttö lääkeaineena
FI960634A0 (fi) Uusia kinolonikarboksyylihappojohdannaisia
DE69718338D1 (de) 3-alkoxyisoxazol-4-yl-substituierte 2-aminocarbonsäurederivate
DE59712000D1 (de) Herstellung von Carbonsäurefluoriden
PL335601A1 (en) Derivatives of 2-substituted benzoylcycloalkyl carboxylic acid
BR9610139A (pt) Derivado de ácido carboxílico
ID20291A (id) Asam-asam oksobutirat tersubstitusi sebagai penghamba-penghambat matriks metaloproteasa
ATE219050T1 (de) Hydroxamsäure-derivate
DE69707882D1 (de) Carbonylierungsverfahren der pentensäuren
ATE221519T1 (de) Ester von 3-hydroxy-piperidinmethanol-derivaten

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: ABBOTT GMBH AND CO. KG (DE)

Free format text: TRANSFERIDO DE: BASF AKTIENGESELLSCHAFT

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE AS 7A E 8A ANUIDADES.